Helen E. Heslop

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

(2023)10.1158/2643-3230.c.6550449

Top 100%

0DataRank

Top 100%0 citations

Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen E. Heslop, Peter Marks +4 more

Papers

Driven by 29 papers — median percentile 0. Top paper: “Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma”.

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Nature Communications(2020)10.1038/s41467-020-17175-8

N/A

4.1DataRank · unranked

169 citations

Sujith K. Joseph, Farzana Pashankar, Christopher DeRenzo, Khaled Sanber, Shoba A. Navai +20 more

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

Nature(2024)10.1038/s41586-024-08261-8

N/A

2.8DataRank · unranked

219 citations

Nisha Ghatwai, Antonino Montalbano, Purva Rathi, Amy N. Courtney, Azlann Arnett +27 more

Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2415

N/A

2.1DataRank · unranked

82 citations

Ifigeneia Tzannou, Meng-Fen Wu, Carlos A. Ramos, Ghadir Sasa, Caridad Martinez +14 more

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Journal of Clinical Oncology(2024)10.1200/jco.23.02019

N/A

1.8DataRank · unranked

75 citations

Austin J. Stuckert, Candise Tat, Mark D. White, Lucia Ruggieri, Huimin Zhang +30 more

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Nature Cancer(2024)10.1038/s43018-024-00749-6

N/A

1.5DataRank · unranked

87 citations

Shoba A. Navai, Christopher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu +32 more

Adoptive T-Cell Therapy for Epstein-Barr Virus–Related Lymphomas

Journal of Clinical Oncology(2021)10.1200/jco.20.01709

N/A

0.574DataRank · unranked

45 citations

Sandhya Sharma, Cliona M. Rooney, Helen E. Heslop

Sensitizing Burkitt lymphoma to EBV-CTLs

Blood(2020)10.1182/blood.2020005492

N/A

0.516DataRank · unranked

7 citations

Helen E. Heslop

Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies

Molecular Therapy(2024)10.1016/j.ymthe.2024.05.039

N/A

0.464DataRank · unranked

21 citations

Helen E. Heslop, Malcolm K. Brenner, Masataka Suzuki, Samer Al Hadidi

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

UNC Libraries(2024)10.17615/xykw-ba83

N/A

0.104DataRank · unranked

1 citations

Riyue Bao, Meenakshi Hegde, Zeid Nawas, Rikhia Chakraborty, Birju Mehta +32 more

Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand–Expressing Solid Tumors

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0115

N/A

0DataRank · unranked

14 citations

Alejandro G. Torres Chavez, Kishore Balasubramanian, Lindsey Fleckenstein, Premal Lulla, Helen E. Heslop +3 more

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

Molecular Therapy(2022)10.1016/j.ymthe.2022.12.006

N/A

0DataRank · unranked

11 citations

Jing Yao, Kimberley House, Lisa Duffy, Prasad S. Adusumilli, Rachel K. Beyer +26 more

Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders

Journal of Allergy and Clinical Immunology(2021)10.1016/j.jaci.2021.07.015

N/A

0DataRank · unranked

24 citations

Olive S. Eckstein, Nitya Gulati, Erin C. Peckham‐Gregory, Nmazuo Ozuah, Joseph Lubega +26 more

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

Science Advances(2023)10.1126/sciadv.ade6790

N/A

0DataRank · unranked

28 citations

Caroline E. Porter, Bora Lim, Amanda Rosewell Shaw, Catherine Robertson, Mae Woods +9 more

A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help

Blood Advances(2023)10.1182/bloodadvances.2023010401

N/A

0DataRank · unranked

12 citations

Sarah Nikiforow, Carlos Bachier, Yen‐Michael S. Hsu, David G. Maloney, Marcela V. Maus +9 more

Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006267

N/A

0DataRank · unranked

11 citations

Mae Woods, Naren Mehta, Tim Sauer, Kathan Parikh, Michael Schmueck‐Henneresse +6 more

Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy

Cytotherapy(2023)10.1016/j.jcyt.2023.11.013

N/A

0DataRank · unranked

9 citations

G. Rosas, Sachin G. Thakkar, Meng-Fen Wu, Virginia Torrano, Tao Wang +6 more

Enhanced anti-tumor activity of CD5 CAR T cells manufactured with tyrosine kinase inhibitors in patients with relapsed/refractory T-ALL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7002

N/A

0DataRank · unranked

12 citations

Rayne H. Rouce, Tyler S. Smith, Blakely Boriskie, Madhuwanti Srinivasan, Sachin G. Thakkar +8 more

Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma

Research Square(2023)10.21203/rs.3.rs-2409436/v1

N/A

0DataRank · unranked

0 citations

Shoba A. Navai, Christpher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu +28 more

Data from Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

(2023)10.1158/2643-3230.c.6550449

Top 100%

0DataRank

Top 100%0 citations

Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen E. Heslop, Peter Marks +4 more

Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0084

N/A

0DataRank · unranked

298 citations

Magdi Elsallab, Steven A. Feldman, Andrew D. Fesnak, Helen E. Heslop, Peter Marks +4 more

Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation

UNC Libraries(2020)10.17615/vsq7-3t37

N/A

0DataRank · unranked

0 citations

Olga Dakhova, Xiaoou Zhou, Gianpietro Dotti, Malcolm K. Brenner, Helen E. Heslop +1 more

Clonal Dynamics

UNC Libraries(2020)10.17615/t3ap-kz12

N/A

0DataRank · unranked

0 citations

Gianpietro Dotti, Helen E. Heslop, Malcolm K. Brenner, Olga Dakhova, David A. Wheeler +4 more

Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors

Cytotherapy(2024)10.1016/j.jcyt.2024.04.075

N/A

0DataRank · unranked

11 citations

Rachel Daum, Tao Wang, Meng‐Fen Wu, Candise Tat, Thomas Pfeiffer +15 more

Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2024)10.17615/t07v-9w63

N/A

0DataRank · unranked

6 citations

Andras Heczey, John M. Maris, Antonino Montalbano, Amy N. Courtney, Jennifer Pogoriler +27 more

Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers

Research Square(2024)10.21203/rs.3.rs-4103623/v1

N/A

0DataRank · unranked

17 citations

David Steffin, Nisha Ghatwai, Antonino Montalbano, Purva Rathi, Amy N. Courtney +26 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

Science Translational Medicine(2020)10.1126/scitranslmed.aaz3339

N/A

0DataRank · unranked

40 citations

Ifigeneia Tzannou, Spyridoula Vasileiou, George Carrum, Carlos A. Ramos, Rammurti T. Kamble +19 more

Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies

Blood Advances(2021)10.1182/bloodadvances.2021004190

N/A

0DataRank · unranked

14 citations

Rammurti T. Kamble, George Carrum, Helen E. Heslop, Carlos A. Ramos, Samer Al Hadidi

Health disparities experienced by Black Americans with multiple myeloma in the United States: A population-based study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18512

N/A

0DataRank · unranked

1 citations

Deepa Dongarwar, Hamisu M. Salihu, Rammurti T. Kamble, Premal Lulla, LaQuisa C. Hill +5 more

Helen E. Heslop

Indexed papers

Top data-sharing exemplar

Papers